by
Lauren Dubinsky, Senior Reporter | March 02, 2020
From the March 2020 issue of HealthCare Business News magazine
“If you’re going to create a great device, you also have to create a methodology by which it fits into the way we practice medicine,” said Martin.
The market at large
Due to the increasing prevalence of diabetes and obesity as well as the growing elderly population, cardiovascular disease is on the rise, and the need for procedures such as transcatheter aortic valve replacement (TAVR), tricuspid valve procedures and mitral valve procedures is increasing. The cardiac ultrasound market is expected to grow from $1.45 billion in 2016 to $1.72 billion in 2023, according to a Market Watch report published in April 2019.
Ad Statistics
Times Displayed: 174127
Times Visited: 3177 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
In August, the FDA approved an expanded indication for TAVR to include patients with severe aortic valve stenosis at low surgical risk. Previously, only patients at high surgical risk were candidates for this procedure.
“There are a lot of hospitals now opening structural heart services, 3D transesophageal echo is now standard of care in these cases, and older equipment won’t necessarily support that new technology,” said Canon’s McElroy.
Back to HCB News